ExponentEXPO
About: Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Employees: 1,320
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
770% more call options, than puts
Call options by funds: $1.86M | Put options by funds: $214K
0% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 50
0.13% less ownership
Funds ownership: 93.57% [Q3] → 93.44% (-0.13%) [Q4]
2% less funds holding
Funds holding: 367 [Q3] → 360 (-7) [Q4]
13% less repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 138
23% less capital invested
Capital invested by funds: $5.46B [Q3] → $4.22B (-$1.24B) [Q4]
25% less funds holding in top 10
Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for EXPO.
Financial journalist opinion
